These discordant findings between EpAT and ThAT suggest that PPAR-γ/adiponectin signaling in EpAT is controlled by local mechanisms, possibly originating in the heart, rather than by systemic effects related to obesity and insulin resistance. The gene discussed is PPARG; the disease is Insulin resistance.